Reperfusion of chronic tissue ischemia: Nitrite and dipyridamole regulation of innate immune responses

Annals of the New York Academy of Sciences

Volumn 1207, Issue , 2010, Pages 83-88

  Pattillo, Christopher B ^a   Fang, Kai ^a   Terracciano, Justin ^a   Kevil, Christopher G ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiogenesis; Inflammation; Interleukin 10; Nitric oxide; Toll like receptors

Indexed keywords

CD14 ANTIGEN; DIPYRIDAMOLE; HEAT SHOCK PROTEIN 90; HEME OXYGENASE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE; NITRITE; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANGIOGENESIS; ARTICLE; DOWN REGULATION; GENE EXPRESSION; INFLAMMATION; INNATE IMMUNITY; ISCHEMIA; MACROPHAGE; NONHUMAN; REPERFUSION; ANIMAL; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; DIPYRIDAMOLE; DOWN-REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRITES; REPERFUSION;

EID: 78149268704     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05737.x     Document Type: Article

References (35)

1. Semenza, G. 2002. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64: 993-998.
2. Heil,M. et al. 2006. Arteriogenesis versus angiogenesis: similarities and differences. J. Cell Mol. Med. 10: 45-55.
3. Pipp, F. et al. 2004. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler. Thromb. Vasc. Biol. 24: 1664-1668.
4. Davies, P.F. et al. 1997. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu. Rev. Physiol. 59: 527-549.
5. Heil,M. et al. 2002. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am. J. Physiol. Heart Circ. Physiol. 283: H2411-H2419.
6. Chidlow, J.H. Jr. et al. 2007. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G5-G18.
7. Mousa, S.A. 2008. Cell adhesion molecules: potential therapeutic& diagnostic implications.Mol. Biotechnol. 38: 33-40.
8. Noonan,D.M. et al. 2008. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev. 27: 31-40.
9. Vannini, N. et al. 2008. Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr. Pharm. Des. 14: 221- 225.
10. Langston, W. et al. 2007. Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis. Free Radic. Biol. Med. 42: 720-729.
11. Ziegler, M.A. et al. Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 17: 3-20.
12. Clayton, J.A., D. Chalothorn & J.E. Faber. 2008. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ. Res. 103: 1027-1036.
13. Dai, X. & J.E. Faber. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ. Res. 106: 1870-1881.
14. Neri Serneri, G.G. et al. 1981. Enhanced prostacyclin production by dipyridamole in man. Eur. J. Clin. Pharmacol. 21: 9-15.
15. Venkatesh, P.K. et al. Dipyridamole enhances ischaemiainduced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc. Res. 85: 661- 670.
16. Aktas, B. et al. 2003. Dipyridamole enhances NO/cGMPmediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke 34: 764-769.
17. Kusmic, C. et al. 2000. Antioxidant effect of oral dipyridamole during cerebral hypoperfusion with human carotid endarterectomy. J. Cardiovasc. Pharmacol. 36: 141-145.
18. Selley, M.L. et al. 1994. Dipyridamole inhibits the oxidative modification of low density lipoprotein. Atherosclerosis 111: 91-97.
19. Elrod, J.W. et al. 2008. Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide. Proc. Natl. Acad. Sci. USA 105: 11430-11435.
20. Kumar, D. et al. 2008. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc. Natl. Acad. Sci. USA 105: 7540-7545.
21. Pattillo, C.B. et al. Genome expression profiling and network analysis of nitrite therapy during chronic ischemia: possible mechanisms and interesting molecules. Nitric Oxide 22: 168-179.
22. Senthilkumar, A. et al. 2007. Sildenafil promotes ischemiainduced angiogenesis through a PKG-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 27: 1947-1954.
23. Schimming, T.T. et al. 2007. Association of toll-interacting protein gene polymorphisms with atopic dermatitis. BMC Dermatol. 7: 3.
24. Ichikawa, D. et al. 2006. TNF-receptor associated factor 6-deficient fibroblast is sensitive to the TNF-alpha-induced cell death: involvement of reactive oxygen species. Biochem. Biophys. Res. Commun. 351: 93-98.
25. Ruckdeschel, K., O. Mannel & P. Schrottner. 2002. Divergence of apoptosis-inducing and preventing signals in bacteria-faced macrophages through myeloid differentiation factor 88 and IL-1 receptor-associated kinase members. J. Immunol. 168: 4601-4611.
26. Garcia-Cardena, G. et al. 1998. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824.
27. Hudson, J.D. et al. 1999. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp.Med. 190: 1375- 1382.
28. Dace, D.S. et al. 2008. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One 3: e3381.
29. Garcia-Hernandez, M.L. et al. 2002. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. Immunology 105: 231-243.
30. Nagata, J. et al. 2002. Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer. Int. J. Mol. Med. 10: 169-172.
31. Sakamoto, T. et al. 2006. Interleukin-10 expression significantly correlates with minor CD8+ T cell infiltration and high microvessel density in patients with gastric cancer. Int. J. Cancer 118: 1909-1914.
32. Silvestre, J.S. et al. 2000.Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 87: 448-452.
33. Lee,M.T. et al. 2007. Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling. Clin. Exp. Immunol. 147: 71-80.
34. Muller, V. et al. 2007. Candida albicans triggers activation of distinct signaling pathways to establish a proinflammatory gene expression programin primary human endothelial cells. J. Immunol. 179: 8435-8445.
35. Macedo, L. et al. 2007.Woundhealing is impaired inMyD88-deficient mice: a role forMyD88 in the regulation of wound healing by adenosine A2A receptors. Am. J. Pathol. 171: 1774-1788